Need Help? sales@qualiketresearch.com     Call Us +1 214 660 5449

Global Human Milk Oligosaccharides (HMOs) Market Size, Trends & Growth Opportunity, By Type (2’FL, 3’FL, 3’SL, and 6’SL), By Application (Infant Formula, Functional Food & Beverage, and Food Supplements), By Distribution Channel (Hypermarkets & Supermarkets, Drug Store or Pharmacy, Mass Merchandiser, Departmental Stores, Mono-brand Stores, Specialty Stores, and Online Sales Channel), and Forecas

Report ID : QR1001465 | Industries : Food and Beverage | Published On :March 2022 | Page Count : 232
Request Sample
Ask for Customization
Inquire Before Buying
Speak to Analyst
Ask for Discount

Global Human Milk Oligosaccharides (HMOs) Market

 

Global Human Milk Oligosaccharides (HMOs) Market generated $125.9 million in 2020, and is expected to reach $332.6 billion by 2028, growing at a CAGR of 14.1% from 2021 to 2028.

 

Human Milk Oligosaccharides (HMOs) are prebiotics that help maintain gut health in humans. They help improve metabolic activity by promoting bacterial growth in the gut, particularly in the bifidobacteria genus. Human milk oligosaccharides have several primary functions, including infection prevention, supply of sialic acid for brain development, and prebiotic effects. Infant formulas made from bovine milk have a lower concentration of oligosaccharides than human milk. Several enzymes and chemicals used in the production of human milk oligosaccharides are extremely expensive and scarce.

 

Drivers: In addition, the increased demand for HMOs has increased the use of a variety of nutritional products as food or dietary supplements. The availability of new technologies such as enzymatic trans-glycosylation, which is used for artificially synthesising HMOs, is one of the major factors and market trends that boosts the Human Milk Oligosaccharides (HMO) market growth.

 

 

Human Milk Oligosaccharides (HMOs) Market

 

Know more about this report: request for sample pages
 

 

Restraints: The HMO market is likely to be constrained by a lack of large-scale production technology, high R&D costs, and strict government regulations.

 

Impact of Covid-19

 

In the early stages of the Covid-19 pandemic, panic buying for at-home consumption drove up demand for HMOs. HMO sales increased dramatically during the pandemic due to its immunity-boosting properties. However, supply chain disruptions resulted in a supply-demand gap. Sales decreased during the lockdown due to the closure of hypermarkets & supermarkets, departmental stores, mono-brand stores, and specialty stores; however, the gap is expected to be filled during the post-lockdown period. However, as restrictions are lifted, sales will increase during the post-lockdown period.

 

Segmentation By Type: Global Human Milk Oligosaccharides (HMOs) Market is classified on the basis of Type into 2’FL, 3’FL, 3’SL, and 6’SL.

 

Segmentation By Application: Global Human Milk Oligosaccharides (HMOs) Market is classified on the basis of Application into Infant Formula, Functional Food & Beverage, and Food Supplements.

 

Segmentation By Distribution Channel: Global Human Milk Oligosaccharides (HMOs) Market is classified on the basis Distribution Channel into Hypermarkets & Supermarkets, Drug Store or Pharmacy, Mass Merchandiser, Departmental Stores, Mono-brand Stores, Specialty Stores, and Online Sales Channel.

 

Segmentation By Region: Global Human Milk Oligosaccharides (HMOs) Market is classified on the basis Region into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

 

 

Competitive Landscape: The key players in Global Human Milk Oligosaccharides (HMOs) Market  are NV (Belgium), Glycom A/S (Denmark), Elicityl (France), Medolac (U.S), Zuchem (U.S), Abbott (U.S), BASF S.E (Germany), Glycosyn LLC (U.S), Dupont De Nemours Inc (U.S), Royal FrieslandCampina N.V (Netherlands), and Jennewein Biotechnologie GmbH (Germany).

 

Recent Developments

 

  • In May 2019, Glycosyn LLC and BASF SE announced a collaboration to develop and market high-molecular-weight oligomers (HMOs) for use in nutritional supplements, healthy nutrition, and therapeutic food.

 

  • Glycosyn LLC and Ginkgo Bioworks announced a USD 14 million deal in November 2018 to optimise and scale the manufacturing of high molecular weight oligomers (HMOs) for a variety of products that promote a healthy gut microbiome ecology and provide medical benefits.

 

  • Inbiose NV announced in October 2018 that it had expanded its portfolio to include seven HMOs with efficient production and commercial procedures that could be used for large-scale manufacturing and distribution.

 

Market Taxonomy

 

By Type

 

  • 2’FL
  • 3’FL
  • 3’SL
  • 6’SL

 

By Application

 

  • Infant Formula
  • Functional Food & Beverage
  • Food Supplements

 

By Distribution Channel

 

  • Hypermarkets & Supermarkets
  • Drug Store or Pharmacy
  • Mass Merchandiser
  • Departmental Stores
  • Mono-brand Stores
  • Specialty Stores
  • Online Sales Channel

 

By Region

 

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

 

Key Questions Addressed by the Report

 

  • What are the Key Opportunities in Global Human Milk Oligosaccharides (HMOs) Market?
  • What will be the growth rate from 2020 to 2027?
  • Which segment/region will have highest growth?
  • What are the factors that will impact/drive the Market?
  • What is the competitive Landscape in the Industry?
  • What is the role of key players in the value chain?

Global Human Milk Oligosaccharides (HMOs) Market TOC

 

1. Introduction

 

1.1 Objective of the Study

1.2 Market definition

1.3 Market Scope

 

2. Research Methodology

 

2.11 Data Mining

2.2 Validation

2.3 Primary Interviews

2.4 List of Data Sources

 

3. Executive Summary

 

4. Global Human Milk Oligosaccharides (HMOs) Market Outlook

 

4.1 Overview

4.2 Market Dynamics

4.2.1 Drivers

4.2.2 Restraints

4.2.3 Opportunities

4.2.4 Challenges

4.3 Porters Five Force Model

4.4 Value Chain Analysis

 

5. Global Human Milk Oligosaccharides (HMOs) Market, By Type 

 

5.1 Y-o-Y Growth Comparison, By Type

5.2 Global Human Milk Oligosaccharides (HMOs) Market  Share Analysis, By Type

5.3 Global Human Milk Oligosaccharides (HMOs) Market Size and Forecast, By Type 

5.3.1 2’FL

5.3.2 3’FL

5.3.3 3’SL

5.3.4 6’SL

 

6. Global Human Milk Oligosaccharides (HMOs) Market, By Distribution Channel

 

6.1 Y-o-Y Growth Comparison, By Distribution Channel

6.2 Global Human Milk Oligosaccharides (HMOs) Market Share Analysis, By Distribution Channel

6.3 Global Human Milk Oligosaccharides (HMOs) Market Size and Forecast, By Distribution Channel

6.3.1 Hypermarkets & Supermarkets

6.3.2 Drug Store or Pharmacy

6.3.3 Mass Merchandiser

6.3.4 Departmental Stores

6.3.5 Mono-brand Stores

6.3.6 Specialty Stores

6.3.7 Online Sales Channel

 

7. Global Human Milk Oligosaccharides (HMOs) Market, By Application

 

7.1 Y-o-Y Growth Comparison, By Application

    1. Global Human Milk Oligosaccharides (HMOs) Market  Share Analysis, By Application
    1. Global Human Milk Oligosaccharides (HMOs) Market  Size and Forecast, By Application
      1. Infant Formula
      2. Functional Food & Beverage
      3. Food Supplements

 

8. Global Human Milk Oligosaccharides (HMOs) Market, By Region

 

8.1 Global Human Milk Oligosaccharides (HMOs) Market Share Analysis, By Region

8.2 Global Human Milk Oligosaccharides (HMOs) Market Size and Forecast, By Region

8.2 Global Human Milk Oligosaccharides (HMOs) Market Size and Forecast, By Region

 

9. North America Human Milk Oligosaccharides (HMOs) Market Analysis and Forecast (2021-2027)

 

9.1 Introduction

9.2 North America Human Milk Oligosaccharides (HMOs) Market Share Analysis, By Type 

9.3 North America Human Milk Oligosaccharides (HMOs) Market Size and Forecast, By Distribution Channel

9.4 North America Human Milk Oligosaccharides (HMOs) Market Size and Forecast, By Application

9.5 North America Human Milk Oligosaccharides (HMOs) Market Size and Forecast, By Country

9.5.1 US

9.5.2 Canada

9.5.3 Mexico

 

10. Europe Human Milk Oligosaccharides (HMOs) Market Analysis and Forecast (2021-2027)

 

10.1 Introduction

10.2 Europe Human Milk Oligosaccharides (HMOs) Market Share Analysis, By Type   

10.3 Europe Human Milk Oligosaccharides (HMOs) Market Size and Forecast, By Distribution Channel

10.4 Europe Human Milk Oligosaccharides (HMOs) Market Size and Forecast, By Application

10.5 Europe Human Milk Oligosaccharides (HMOs) Market Size and Forecast, By Country

10.5.1 UK

10.5.2 Germany

10.5.3 France

10.5.4 Rest of Europe (Russia, Spain, Finland, Denmark, Italy, Greece, and Sweden)

 

11. Asia Pacific Human Milk Oligosaccharides (HMOs) Market Analysis and Forecast (2021-2027)

 

11.1­­­­­­­­­­­­­­­­­ Introduction

11.2 Asia Pacific Human Milk Oligosaccharides (HMOs) Market Share Analysis, By Type 

11.3 Asia Pacific Human Milk Oligosaccharides (HMOs) Market Size and Forecast, By Distribution Channel

11.4 Asia Pacific Human Milk Oligosaccharides (HMOs) Market Size and Forecast, By Application

11.5 Asia Pacific Human Milk Oligosaccharides (HMOs) Market Size and Forecast, By Country

11.5.1 China

11.5.2 India

11.5.3 Japan

11.5.4 South Korea

11.2.5 Rest of Asia Pacific (Hong Kong, Australia, Singapore, New Zealand, Indonesia, Malaysia, and Taiwan)

 

12 Latin America Human Milk Oligosaccharides (HMOs) Market Analysis and Forecast (2021-2027)


12.1 Introduction

12.2 Latin America Human Milk Oligosaccharides (HMOs) Market Share Analysis, By Type 

12.3 Latin America Human Milk Oligosaccharides (HMOs) Market Size and Forecast, By Distribution Channel

12.4 Latin America Human Milk Oligosaccharides (HMOs) Market Size and Forecast, By Application

12.5 Latin America Human Milk Oligosaccharides (HMOs) Market Size and Forecast, Country

12.5.1. Brazil

12.5.2. Rest of Latin America

 

13 Middle East Human Milk Oligosaccharides (HMOs) Market Analysis and Forecast (2021-2027)


13.1 Introduction

13.2 Middle East Human Milk Oligosaccharides (HMOs) Market Share Analysis, By Type 

12.3 Middle East Human Milk Oligosaccharides (HMOs) Market Size and Forecast, By Distribution Channel

13.4 Middle East Human Milk Oligosaccharides (HMOs) Market Size and Forecast, By Application

13.5 Middle East Human Milk Oligosaccharides (HMOs) Market Size and Forecast, By Country

13.5.1. Saudi Arabia

13.5.2. UAE

13.5.3. Egypt

13.5.4. Kuwait

13.5.5. South Africa

 

14. Competitive Analysis

 

14.1 Competition Dashboard

14.2 Market share Analysis of Top Vendors

14.3 Key Development Strategies

 

15. Company Profiles

 

15.1 NV (Belgium)

 

15.1. Overview

15.1.2 Offerings

15.1.3 Key Financials

15.1.4 Business Segment & Geographic Overview

15.1.5 Key Market Developments

15.1.6 Key Strategies

 

15.2 Glycom A/S (Denmark)

 

15.2.1. Overview

15.2.2 Offerings

15.2.3 Key Financials

15.2.4 Business Segment & Geographic Overview

15.2.5 Key Market Developments

15.2.6 Key Strategies

 

15.3. Elicityl (France)

 

15.3.1 Overview

15.3.2 Offerings

15.3.3 Key Financials

15.3.4 Business Segment & Geographic Overview

15.3.5 Key Market Developments

15.3.6 Key Strategies

 

15.4. Medolac (U.S)

 

15.4.1 Overview

15.4.2 Offerings

15.4.3 Key Financials

15.4.4 Business Segment & Geographic Overview

15.4.5 Key Market Developments

15.4.6 Key Strategies

 

15.5. Zuchem (U.S)

 

15.5.1 Overview

15.5.2 Offerings

15.5.3 Key Financials

15.5.4 Business Segment & Geographic Overview

15.5.5 Key Market Developments

15.5.6 Key Strategies

 

15.6. Abbott (U.S)

 

15.6.1 Overview

15.6.2 Offerings

15.6.3 Key Financials

15.6.4 Business Segment & Geographic Overview

15.6.5 Key Market Developments

15.6.6 Key Strategies

 

15.7. BASF S.E (Germany)

 

15.7.1 Overview

15.7.2 Offerings

15.7.3 Key Financials

15.7.4 Business Segment & Geographic Overview

15.7.5 Key Market Developments

15.7.6 Key Strategies

Inquiry Before Buying
Request Free Sample
Ask For Discount